UB Paderborn / Katalog / Suche / in CDI

1 – 12 von 12

Sortiert nach

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II

Alimentary pharmacology & therapeutics, 2022-04, Vol.55 (7), p.856-866

2022

Volltextzugriff (PDF)

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study

Digestive and liver disease, 2018-12, Vol.50 (12), p.1299-1304

2018

Volltextzugriff (PDF)

Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation

Bioorganic & medicinal chemistry letters, 2013-07, Vol.23 (13), p.3741-3748

2013

Volltextzugriff (PDF)

Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase Inhibitor

Journal of medicinal chemistry, 2022-06, Vol.65 (12), p.8345-8379

2022

Volltextzugriff (PDF)

Telehealth Autism Diagnostic Assessments With Children, Young People, and Adults: Qualitative Interview Study With England-Wide Multidisciplinary Health Professionals

JMIR mental health, 2022-07, Vol.9 (7), p.e37901-e37901

2022

Volltextzugriff (PDF)

Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors

Bioorganic & medicinal chemistry letters, 2016-10, Vol.26 (19), p.4729-4734

2016

Volltextzugriff (PDF)

Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors

Bioorganic & medicinal chemistry letters, 2015-09, Vol.25 (17), p.3575-3581

2015

Volltextzugriff (PDF)

Corrigendum to “Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation” [Bioorg. Med. Chem. Lett. 23 (2013) 3741–3748]

Bioorganic & medicinal chemistry letters, 2013-08, Vol.23 (16), p.4723-4723

2013

Volltextzugriff (PDF)

Abstract 1922: 2-Aminothiazoles as potent and selective PI3Kalpha inhibitors: Discovery of NVP-BYL719 and structural basis for the isoform selectivity

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1922-1922

2012

Volltextzugriff (PDF)

Organisational communication

Handbook of Business Discourse, 2009, p.256-268

2009

Volltextzugriff (PDF)

Synthesis and dopamine antagonist activity of 2-thioether derivatives of the ergoline ring system

Journal of medicinal chemistry, 1993-04, Vol.36 (7), p.912-918

1993

Volltextzugriff (PDF)

Heteroarenobenzodiazepines. 4. 10-Piperazinyl-4H-thieno[3,2-b][1,5]- and -[3,4-b][1,5]benzodiazepines as potential neuroleptics

Journal of medicinal chemistry, 1980-08, Vol.23 (8), p.884-889

1980

Volltextzugriff (PDF)

1 – 12 von 12

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(11)
Buchkapitel
(1)

Sprache

Englisch
(12)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study

Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation

Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase Inhibitor

Telehealth Autism Diagnostic Assessments With Children, Young People, and Adults: Qualitative Interview Study With England-Wide Multidisciplinary Health Professionals

Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors

Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors

Corrigendum to “Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation” [Bioorg. Med. Chem. Lett. 23 (2013) 3741–3748]

Abstract 1922: 2-Aminothiazoles as potent and selective PI3Kalpha inhibitors: Discovery of NVP-BYL719 and structural basis for the isoform selectivity

Organisational communication

Synthesis and dopamine antagonist activity of 2-thioether derivatives of the ergoline ring system

Heteroarenobenzodiazepines. 4. 10-Piperazinyl-4H-thieno[3,2-b][1,5]- and -[3,4-b][1,5]benzodiazepines as potential neuroleptics

Suchergebnisse filtern